CryoSpray Ablation(tm)Thoracic Patient Registry
NCT00785239 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2015-06-25
Summary
The purpose of this study is to create a patient registry to collect and analyze information on subjects treated with the CryoSpray Ablation™ System post-510K approval.
Conditions
- Lung Cancer
- Emphysema
- Chronic Bronchitis
- COPD
- Asthma
- Sarcoidosis
- Mesothelioma
Sponsors & Collaborators
-
Reset Medical, Inc.
collaborator INDUSTRY -
CSA Medical, Inc.
lead INDUSTRY
Principal Investigators
-
William Krimsky, M.D. · Franklin Square Hospital Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
- Primary Completion
- 2009-04-30
- Completion
- 2009-04-30
More Related Trials
-
Pulmonary Deposition of Ultrasound Rock Salt Aerosol Inhalation Therapy
NCT06891274 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)
NCT01449292 ·Status: TERMINATED ·Phase: PHASE3
-
Pilot Study of the Spiration IBV™ System
NCT00145548 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled GM-CSF for Respiratory Virus-Associated Severe Pneumonia
NCT02601365 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection
NCT06016088 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT07048262 ·Status: RECRUITING ·Phase: PHASE2
-
Cough Desensitization Therapy: Pilot 2
NCT05226299 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema
NCT01908933 ·Status: WITHDRAWN ·Phase: PHASE3
-
COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2
NCT04858451 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis
NCT06589219 ·Status: RECRUITING ·Phase: PHASE1
-
STRIVE Post-Market Registry Study
NCT04302272 ·Status: RECRUITING
-
Tiotropium Handihaler vs. Tiotropium Respimat in COPD
NCT05838703 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
NCT03903913 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
NCT04472494 ·Status: TERMINATED ·Phase: PHASE2
-
Phase III Randomized Study of the Inhalation of Tobramycin in Patients With Cystic Fibrosis
NCT00004829 ·Status: COMPLETED ·Phase: PHASE3
-
Stimulation of the Larynx to Treat Unexplained Chronic Cough
NCT05273190 ·Status: RECRUITING ·Phase: NA
-
Nasal Muco-ciliary Clearance Study With and Without Salt Inhalation
NCT04189016 ·Status: UNKNOWN ·Phase: NA
-
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
NCT06872892 ·Status: RECRUITING ·Phase: PHASE3
-
Single Ascending Dose Study of TRN-157 in Healthy Subjects
NCT02133339 ·Status: COMPLETED ·Phase: PHASE1
-
The Spiration Valve System for the Treatment of Severe Emphysema
NCT01989182 ·Status: COMPLETED ·Phase: NA
-
Comparative Effectiveness and Safety of Inhaled Corticosteroids and Antimicrobial Compounds for Non-CF Bronchiectasis
NCT02714283 ·Status: COMPLETED
-
Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
NCT02468908 ·Status: COMPLETED ·Phase: PHASE1
-
Novel Therapies for Muco-Obstructive Lung Diseases: Testing the Transnasal Pulmonary Delivery Device in COPD/CB Subjects
NCT02341183 ·Status: WITHDRAWN ·Phase: NA
-
TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis
NCT04589260 ·Status: TERMINATED ·Phase: PHASE1
-
Phase 3 Study of the Biologic Lung Volume Reduction (BLVR) System in Advanced Upper Lobe Predominant (ULP) Emphysema
NCT00716053 ·Status: WITHDRAWN ·Phase: PHASE3